Xenon Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares
November 10, 2014 at 16:12 PM EST
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical-stage biopharmaceutical company, today announced the closing of its previously ...